GEMCITABINE, DEXAMETHASONE, AND CISPLATIN (GDP): EFFECTIVE AND WELL-TOLERATED SALVAGE THERAPY FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA (HL)

被引：0
|
作者：
Moccia, A. A. [1 ,2 ]
Hoskins, P. [1 ,2 ]
Klasa, R. [1 ,2 ]
Savage, K. J. [1 ,2 ]
Shenkier, T. [1 ,2 ]
Skinnider, B. [2 ,3 ]
Slack, G. [2 ,3 ]
Gascoyne, R. D. [2 ,3 ]
Connors, J. M. [1 ,2 ]
Sehn, L. H. [1 ,2 ]
机构：
[1] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC, Canada
来源：
HAEMATOLOGICA | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P097
引用
收藏
页码：S28 / S29
页数：2
相关论文
共 50 条
  • [1] Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma
    Moccia, Alden A.
    Hitz, Felicitas
    Hoskins, Paul
    Klasa, Richard
    Power, Maryse M.
    Savage, Kerry J.
    Shenkier, Tamara
    Shepherd, John D.
    Slack, Graham W.
    Song, Kevin W.
    Gascoyne, Randy D.
    Connors, Joseph M.
    Sehn, Laurie H.
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (02) : 324 - 332
  • [2] Gemcitabine, Dexamethasone, and Cisplatin (GDP) Is An Effective and Well-Tolerated out-Patient Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Hodgkin Lymphoma (HL)
    Moccia, Alden A.
    Hitz, Felicitas
    Hoskins, Paul
    Klasa, Richard
    Power, Maryse
    Savage, Kerry J.
    Shenkier, Tamara
    Shepherd, John
    Skinnider, Brian
    Slack, Graham W.
    Song, Kevin
    Gascoyne, Randy D.
    Connors, Joseph M.
    Sehn, Laurie
    [J]. BLOOD, 2010, 116 (21) : 56 - 56
  • [3] Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
    Batgi, Hikmettullah
    Basci, Semih
    Dal, Mehmet Sinan
    Kizil Cakar, Merih
    Uncu Ulu, Bahar
    Yigenoglu, Tugce Nur
    Ozcan, Nurgul
    Kilinc, Ali
    Merdin, Alparslan
    Yildiz, Jale
    Bakirtas, Mehmet
    Sahin, Derya
    Darcin, Tahir
    Iskender, Dicle
    Baysal, Nuran Ahu
    Altuntas, Fevzi
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (02) : 685 - 692
  • [4] Gemcitabine, dexamethasone, and cisplatin (GDP) as an effective therapy as salvage and mobilization regimen in patients with relapsed or refractory Hodgkin lymphoma.
    Gokmen, Ayla
    Soydan, Ender
    Gokgoz, Zafer
    Kurdal, Mevlude
    Tek, Ibrahim
    Ilhan, Osman
    Arslan, Onder
    Ozcan, Muhit
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
    Wang, Jing-jing
    Dong, Mei
    He, Xiao-hui
    Li, Ye-xiong
    Wang, Wei-hu
    Liu, Peng
    Yang, Jian-liang
    Gui, Lin
    Zhang, Chang-gong
    Yang, Sheng
    Zhou, Sheng-yu
    Shi, Yuan-kai
    [J]. MEDICINE, 2016, 95 (06)
  • [6] GEMCITABINE (GEMZAR) AS A SALVAGE THERAPY AT RELAPSED AND REFRACTORY HODGKIN'S LYMPHOMA
    Violeta, V.
    Jankovic, S.
    Andjelic, B.
    Bogunovic, M.
    Petrovic, M.
    Mihaljevic, B.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 637 - 637
  • [7] GEMCITABINE, DEXAMETHASONE AND CISPLATIN IS EFFECTIVE AS A SALVAGE CHEMOTHERAPY REGIMEN IN RELAPSED OR REFRACTORY HODGKIN'S DISEASE PRIOR TO ASCT
    Precupanu, C. M.
    Senecal, D.
    Lissandre, S.
    Delain, M.
    Dartigeas, C.
    Radesi, S.
    Venel, Y.
    Benboubker, L.
    Herault, O.
    Colombat, P.
    Gyan, E.
    [J]. HAEMATOLOGICA, 2012, 97 : 564 - 564
  • [8] Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma—not otherwise specified
    Fei Qi
    Mei Dong
    Xiaohui He
    Yexiong Li
    Weihu Wang
    Peng Liu
    Jianliang Yang
    Lin Gui
    Changgong Zhang
    Sheng Yang
    Shengyu Zhou
    Yuankai Shi
    [J]. Annals of Hematology, 2017, 96 : 245 - 251
  • [9] Gemcitabine, Dexamethasone and Cisplatin (GDP regimen) As First Salvage Treatment of Patients with Refractory or Relapsed Diffuse large B Cell Non Hodgkin Lymphoma (DLBCL)
    Hamid, Thoraya Mohamed Abdel
    Ramadan, Mona Fawzy
    Bahnassy, Abeer
    Abu-Taleb, Fouad
    Saber, Magdy
    [J]. BLOOD, 2011, 118 (21) : 1159 - 1159
  • [10] The efficacy and safety of gemcitabine, dexamethasone, and cisplatine (GDP) therapy for relapsed/refractory lymphoma
    Nozawa, Kazuki
    Sugiyama, Keiji
    Hasegawa, Yuta
    Nakamura, Hiroyuki
    Hirano, Daiki
    Tokunaga, Takashi
    Miyata, Yasuhiko
    Kunitomi, Akane
    Ida, Hiroatsu
    Nagai, Hirokazu
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 147 - 148
12345